1
|
Ben-Bassat H, Polliack A, Shlomai Z, Kohn G, Hadar R, Rabinowitz R, Leizerowitz R, Matutes E, Buchier V, Brok-Simoni F, Okon E, Livni N, Schlesinger M. Farage, a Novel Early B Cell Lymphoma Cell Line with Trisomy 11. Leuk Lymphoma 2009. [DOI: 10.3109/10428199209053591] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Affiliation(s)
- Hannah Ben-Bassat
- Laboratory of Experimental Surgery, Hadassah University Hospital, Holon, Israel
- The Paul Ehrlich Center for the Study of Normal and Leukemic White Blood Cells, Holon, Israel
| | - Aaron Polliack
- Department of Hematology, Hadassah University Hospital, Holon, Israel
- The Paul Ehrlich Center for the Study of Normal and Leukemic White Blood Cells, Holon, Israel
| | - Ziporah Shlomai
- Laboratory of Experimental Surgery, Hadassah University Hospital, Holon, Israel
| | - Gertrude Kohn
- The Hebrew University, Jerusalem and the Institute for Medical Genetics Wolfson, Holon, Israel
| | - Rivka Hadar
- Hadassah University Hospital, Department of Experimental Medicine and Cancer Research, Holon, Israel
- The Paul Ehrlich Center for the Study of Normal and Leukemic White Blood Cells, Holon, Israel
| | - Ruth Rabinowitz
- Hadassah University Hospital, Department of Experimental Medicine and Cancer Research, Holon, Israel
- The Paul Ehrlich Center for the Study of Normal and Leukemic White Blood Cells, Holon, Israel
| | | | - Estella Matutes
- Department of Hematology and Cytogenetics, The Royal Marsden Hospital, Fulham Road, London, UK
| | - Valerie Buchier
- Department of Hematology and Cytogenetics, The Royal Marsden Hospital, Fulham Road, London, UK
| | - Frida Brok-Simoni
- Department of Hematology, The Ch. Sheba Medical Center, Tel-Hashomer, Israel
| | - Elimelech Okon
- Department of Pathology, Hadassah University Hospital, Holon, Israel
| | - Nelly Livni
- Department of Pathology, Hadassah University Hospital, Holon, Israel
| | - Michael Schlesinger
- Hadassah University Hospital, Department of Experimental Medicine and Cancer Research, Holon, Israel
- The Paul Ehrlich Center for the Study of Normal and Leukemic White Blood Cells, Holon, Israel
| |
Collapse
|
2
|
Avanzi GC, Giovinazzo B, Rosso A, Depaoli L, Bertini M, Resegotti L, Pegoraro L. Trisomy 11 in myelodysplastic syndrome-derived acute myeloblastic leukaemias. Eur J Haematol Suppl 1989; 43:173-7. [PMID: 2792325 DOI: 10.1111/j.1600-0609.1989.tb00274.x] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
Here we report 3 cases of trisomy 11 observed in 1 patient with secondary acute myeloblastic leukaemia and in 2 patients with spontaneous acute myeloblastic leukaemia. In all 3 patients, the picture of overt acute leukaemia arose following a clinically established myelodysplastic syndrome. These findings, together with the previously reported occurrence of trisomy 11 in myelodysplastic syndrome and in acute myeloblastic leukaemia, suggest that this abnormality can be considered specifically associated with myelodysplastic syndrome and with the subsequent and related acute myeloblastic leukaemia.
Collapse
Affiliation(s)
- G C Avanzi
- Instituto di Medicina Interna, Università degli Studi di Torino, Italy
| | | | | | | | | | | | | |
Collapse
|
3
|
Ohyashiki K, Nagasu M, Hojo H, Iwabuchi A, Ohyashiki JH, Toyama K. Myelodysplastic syndrome with trisomy 11 associated with polycythemia vera. Am J Hematol 1989; 31:122-5. [PMID: 2735317 DOI: 10.1002/ajh.2830310209] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
A 52-year-old male with myelodysplastic syndrome (MDS) who had a prior history of polycythemia vera is reported. Chromosome analysis revealed that the bone marrow and blood cells at the MDS phase contained trisomy of chromosome 11 as the sole cytogenetic change. Trisomy 11 is rarely found in hematologic neoplasia, and all of the reported cases with trisomy 11 were diagnosed as having nonlymphocytic neoplasia. In this report, a correlation between the chromosome change and leukemia/MDS developed in polycythemia vera is discussed.
Collapse
Affiliation(s)
- K Ohyashiki
- First Department of Internal Medicine, Tokyo Medical College, Japan
| | | | | | | | | | | |
Collapse
|
4
|
Reid MM, Davison EV, Bown N. Trisomy 11 in acute lymphoblastic leukaemia. J Clin Pathol 1989; 42:555-6. [PMID: 2732351 PMCID: PMC1141969 DOI: 10.1136/jcp.42.5.555-b] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
|
5
|
Weh HJ, Hoffmann R, Suciu S, Kuse R, Hossfeld DK. Is trisomy 11 another nonrandom chromosomal anomaly in acute nonlymphocytic leukemia and myelodysplastic syndromes? CANCER GENETICS AND CYTOGENETICS 1988; 35:205-11. [PMID: 3180022 DOI: 10.1016/0165-4608(88)90242-7] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
Four cases with trisomy 11 as the sole chromosomal anomaly are reported, three with de novo acute nonlymphocytic leukemia (ANLL) and one with a myelodysplastic syndrome (MDS) after treatment for multiple myeloma. In reviewing the literature, we found 19 additional cases with trisomy 11 as the sole cytogenetic defect. All patients except one were reported to have ANLL or MDS. Thus, it seems that trisomy 11 is another rare but nonrandom chromosomal anomaly in ANLL and MDS. So far, no apparently characteristic clinical or cytologic signs have been found in these cases.
Collapse
Affiliation(s)
- H J Weh
- Department of Oncology and Hematology, Medical University Clinic, Hamburg, FRG
| | | | | | | | | |
Collapse
|
6
|
Ohyashiki K, Ohyashiki JH, Iwabuchi A, Toyama K, Fukui M, Yoshitake H, Okajima S. Trisomy 11 in nonlymphocytic neoplasia. Br J Haematol 1988; 69:420. [PMID: 3165669 DOI: 10.1111/j.1365-2141.1988.tb02384.x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Affiliation(s)
- K Ohyashiki
- Department of Internal Medicine, Tokyo Medical College, Japan
| | | | | | | | | | | | | |
Collapse
|
7
|
Takasaki N, Kaneko Y, Maseki N, Sakurai M. Trisomy 11 in chronic myelomonocytic leukemia: report of two cases and review of the literature. CANCER GENETICS AND CYTOGENETICS 1988; 30:109-17. [PMID: 3275488 DOI: 10.1016/0165-4608(88)90098-2] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Abstract
Two cases of chronic myelomonocytic leukemia (CMMoL) with trisomy 11 as the sole chromosome abnormality are reported. A simple trisomy 11 also has been reported in 11 patients with myeloproliferative disorders, including CMMoL and acute nonlymphocytic leukemia (ANLL) in the literature. From data on these 13 patients, leukemia with trisomy 11 may be characterized by a nonlymphoid origin and myelomonocytic features. Patients with this abnormality were mostly elderly, and often had a preleukemic phase and a short survival. We propose that trisomy 11 and nonlymphocytic leukemia with myelomonocytic features may be a new association in human neoplasia.
Collapse
Affiliation(s)
- N Takasaki
- Department of Cancer Chemotherapy, Saitama Cancer Center, Japan
| | | | | | | |
Collapse
|
8
|
Abstract
A case of pancytopenia with dysplastic changes in the bone marrow with trisomy 11 (+11) as the sole karyotypic anomaly in an adult male is described. The literature on +11, both as a primary (14 cases) and secondary (55 cases) cytogenetic event in hematologic disorders, is summarized and the findings are discussed. There is the possibility that +11 is a nonrandom chromosomal anomaly in some myelodysplastic disorders.
Collapse
Affiliation(s)
- R Morgan
- Genetics Center Southwest Biomedical Research Institute, Scottsdale, AZ 85345
| | | | | |
Collapse
|